Drug Guide
Cetirizine Hydrochloride
Classification
Therapeutic: Antihistamine, Allergy Agent
Pharmacological: Piperazine Derivative H1 Receptor Antagonist
FDA Approved Indications
- Allergic rhinitis (seasonal and perennial)
- Chronic urticaria (hives)
Mechanism of Action
Cetirizine selectively antagonizes peripheral H1 receptors, thereby reducing the allergic response caused by histamine.
Dosage and Administration
Adult: 10 mg once daily, can be adjusted based on response and tolerability.
Pediatric: 2-6 years: 5 mg once daily; over 6 years: 10 mg once daily.
Geriatric: Start with lower dose in elderly; monitor for sedation and anticholinergic effects.
Renal Impairment: Dose adjustment needed; typically 5 mg or less in severe impairment.
Hepatic Impairment: Use with caution; no specific dose adjustment recommended, but monitor for adverse effects.
Pharmacokinetics
Absorption: Rapidly absorbed with peak plasma concentrations at ~1 hour.
Distribution: Widely distributed; crosses the blood-brain barrier minimally.
Metabolism: Minimal hepatic metabolism; primarily excreted unchanged.
Excretion: Urinary excretion of unchanged drug; also through feces.
Half Life: Approx. 8 hours (adults); longer in renal impairment.
Contraindications
- Hypersensitivity to cetirizine or hydroxyzine.
- Children under 2 years of age for some formulations.
Precautions
- Use with caution in renal or hepatic impairment.
- Monitor for sedation and anticholinergic effects.
- Use caution in elderly due to increased sensitivity.
Adverse Reactions - Common
- Drowsiness (Common)
- Headache (Common)
- Dry mouth (Less common)
- Fatigue (Less common)
Adverse Reactions - Serious
- Pruritus, rash, or other hypersensitivity reactions (Rare)
- Cardiovascular reactions (e.g., tachycardia) (Rare)
Drug-Drug Interactions
- Other central nervous system depressants (increased sedation)
- Theophylline (may alter clearance)
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor for effectiveness and adverse effects, especially sedation.
Diagnoses:
- Risk for sedation related to CNS effects.
- Risk for allergic reaction if hypersensitive.
Implementation: Administer with or without food. Advise patient to avoid alcohol and CNS depressants.
Evaluation: Assess relief of allergy symptoms and adverse effects.
Patient/Family Teaching
- Take medication as prescribed.
- Avoid alcohol and sedatives while taking cetirizine.
- Report any signs of allergic reactions or unusual side effects.
Special Considerations
Black Box Warnings:
- No black box warnings for cetirizine.
Genetic Factors: Consider genetic variability in metabolism, though unlikely to impact typical dosing.
Lab Test Interference: No known significant interference with laboratory tests.
Overdose Management
Signs/Symptoms: Severe drowsiness, hallucinations, agitation, or seizures in overdose.
Treatment: Supportive care, activated charcoal if ingestion is recent, gastric lavage, and monitoring. No specific antidote.
Storage and Handling
Storage: At room temperature, away from moisture and light.
Stability: Stable under recommended storage conditions.